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Abstract: Microbial degradation of chiral compounds during wastewater treatment 
processes can be enantioselective and needs chiral analytical methodology to 
discriminate the biodegradation of both enantiomers. An enantioselective HPLC-FD 
method was developed and validated to monitor the degradation of fluoxetine (FLX) 
enantiomers by wastewater and the possible formation of its metabolite norfluoxetine 
(NFLX). The Solid Phase Extraction (SPE) of 50 mL of wastewater samples on 500 mg Oasis 
MCX cartridges was followed by the HPLC analysis using a Chirobiotic V chiral stationary 
phase under reversed mode. The developed method was validated within the wastewater 
effluent used in microcosms laboratory assays. The chiral SPE-HPLC-FD method 
demonstrated to be selective, linear, sensitive, accurate and precise to quantify the 
enantiomers of FLX and of its metabolites NFLX in wastewaters. The limits of detection 
(0.8-2.0 ng mL
-1
) and quantification (2.0 – 4.0 ng mL
-1
) were adequate to monitoring the 
degradation assays at environmental level. The method proved to be robust to follow the 
biodegradation assays using real wastewater samples spiked with FLX, during 46 days. To 
the best of our knowledge, this is the first report of simultaneous separation of FLX and 
NFLX enantiomers using a Chirobiotic V and the application of the validated method to 
the enantioselective degradation by wastewater. 
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